GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION

Side Effects & Adverse Event Reports


View Chart Data

4.6K

Adverse Events

19.5K

Side Effects

1999

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION.

Understanding the potential Side Effects and Adverse Events of GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION?

    SymPedia shows GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION adverse event reports for 4,592.

  • How many side effects have been reported for GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION?

    SymPedia shows GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION side effect reports for 19,479.

  • What year does the GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION reporting data start?

    SymPedia reporting data on this page starts in 1999.

  • What years are included in the yearly chart for GENTAMICIN (AS GENTAMICIN SULFATE) 0.3 % OPHTHALMIC SOLUTION?

    SymPedia yearly chart data on this page covers 1999 to 2025.